Q3 2018 13F Holders as of 9/30/2018
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
48M
-
Number of holders
-
51
-
Total 13F shares, excl. options
-
7.61M
-
Shares change
-
+3.14M
-
Total reported value, excl. options
-
$133M
-
Value change
-
+$55M
-
Number of buys
-
32
-
Number of sells
-
-20
-
Price
-
$17.50
Significant Holders of BIOLIFE SOLUTIONS INC - Common Stock, par value $0.001 per share (BLFS) as of Q3 2018
57 filings reported holding BLFS - BIOLIFE SOLUTIONS INC - Common Stock, par value $0.001 per share as of Q3 2018.
BIOLIFE SOLUTIONS INC - Common Stock, par value $0.001 per share (BLFS) has 51 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 7.61M shares
of 48M outstanding shares and own 15.85% of the company stock.
Largest 10 shareholders include Casdin Capital, LLC (2.43M shares), SANDLER CAPITAL MANAGEMENT (784K shares), DRIEHAUS CAPITAL MANAGEMENT LLC (504K shares), Vanguard Group Inc (448K shares), RENAISSANCE TECHNOLOGIES LLC (428K shares), Venator Capital Management Ltd. (403K shares), Schonfeld Strategic Advisors LLC (369K shares), ESSEX INVESTMENT MANAGEMENT CO LLC (275K shares), MILLENNIUM MANAGEMENT LLC (213K shares), and BlackRock Inc. (154K shares).
This table shows the top 51 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.